Ovid Therapeutics (OVID) Return on Sales [ROS] (2020 - 2026)
Ovid Therapeutics' Return on Sales [ROS] came in at -2141.61% for Q2 2026, down 2060.73 percentage points from -80.88% a year earlier and down 1471.36 percentage points from the prior quarter.
Ovid Therapeutics (OVID) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ovid Therapeutics reported Return on Sales [ROS] of -3686.67%, down 3061.64 percentage points year-over-year; for FY2025, it was -585.20%, up 10348.54 percentage points from FY2024.
- Return on Sales [ROS] carries a five-year change of +60.19 percentage points (FY2020 to FY2025).
- Going back by year, Return on Sales [ROS] was -10933.75% in FY2024 (+4188.96 pp), -15122.70% in FY2023 (-11426.27 pp), -3696.44% in FY2022 (-3756.05 pp) and 59.61% in FY2021 (+705.00 pp).
- The five-year range for quarterly Return on Sales [ROS] is -115329.27% (Q3 2022) to 60.24% (Q3 2021).
- Year-over-year, Return on Sales [ROS] increased in five of the last eight quarters, with an average year-over-year change of +4217.70 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q3 2023 (a gain of 104293.49 percentage points), and the weakest in Q3 2022 (a drop of 115389.52 percentage points).
- Business Quant data shows OVID's Return on Sales [ROS] at -670.25% (Q1 2026), -1712.12% (Q4 2025) and -9487.12% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Ovid Therapeutics | 439.72 Mn | 71.74 Mn | - | -2,141.61% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,141.61% |
| Mar 31, 2026 | -670.25% |
| Dec 31, 2025 | -1,712.12% |
| Sep 30, 2025 | -9,487.12% |
| Jun 30, 2025 | -80.88% |
| Mar 31, 2025 | -9,653.85% |
| Dec 31, 2024 | -14,107.89% |
| Sep 30, 2024 | -7,645.09% |
| Jun 30, 2024 | -12,140.24% |
| Mar 31, 2024 | -11,768.24% |
| Dec 31, 2023 | -12,808.45% |
| Sep 30, 2023 | -11,035.78% |
| Jun 30, 2023 | -18,896.00% |
| Mar 31, 2023 | -22,563.64% |
| Dec 31, 2022 | -26,302.75% |
| Sep 30, 2022 | -115,329.27% |
| Jun 30, 2022 | -4,746.67% |
| Mar 31, 2022 | -1,125.47% |
| Dec 31, 2021 | 59.61% |
| Sep 30, 2021 | 60.24% |
Ovid Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();